Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.
Reiberger T, Payer BA, Ferlitsch A, Sieghart W, Breitenecker F, Aichelburg MC, Schmied B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab and Vienna HIV & Liver Study Group. Reiberger T, et al. Among authors: payer ba. Antivir Ther. 2012;17(7):1327-34. doi: 10.3851/IMP2349. Epub 2012 Sep 5. Antivir Ther. 2012. PMID: 22948263
Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
Mandorfer M, Reiberger T, Payer BA, Ferlitsch A, Breitenecker F, Aichelburg MC, Obermayer-Pietsch B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna HIV & Liver Study Group. Mandorfer M, et al. Among authors: payer ba. AIDS. 2013 Jan 14;27(2):227-32. doi: 10.1097/QAD.0b013e32835aa161. AIDS. 2013. PMID: 23238552
Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin.
Mandorfer M, Payer BA, Scheiner B, Breitenecker F, Aichelburg MC, Grabmeier-Pfistershammer K, Rieger A, Trauner M, Peck-Radosavljevic M, Reiberger T. Mandorfer M, et al. Among authors: payer ba. Liver Int. 2014 Jan;34(1):69-77. doi: 10.1111/liv.12253. Epub 2013 Jul 29. Liver Int. 2014. PMID: 23890125
Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting.
Mandorfer M, Payer BA, Niederecker A, Lang G, Aichelburg MC, Strassl R, Boesecke C, Rieger A, Trauner M, Peck-Radosavljevic M, Reiberger T. Mandorfer M, et al. Among authors: payer ba. AIDS Patient Care STDS. 2014 May;28(5):221-7. doi: 10.1089/apc.2013.0359. AIDS Patient Care STDS. 2014. PMID: 24796757
Concomitant highly active antiretroviral therapy leads to smaller decline and faster recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected patients.
Reiberger T, Payer BA, Kosi L, Heil PM, Rieger A, Peck-Radosavljevic M; Vienna HIV Coinfection Study Group. Reiberger T, et al. Among authors: payer ba. J Infect Dis. 2011 Jun 15;203(12):1802-6. doi: 10.1093/infdis/jir194. J Infect Dis. 2011. PMID: 21606538
35 results